We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$71.3B
1-Year Est. Return
56.8%
This Fund
S&P 500
This Quarter
Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
(+10%)
Cap. Flow
-$2.43B
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Devon Energy
DVN
|
+$353M |
| 2 |
Marvell Technology
MRVL
|
+$150M |
| 3 |
Spyre Therapeutics
SYRE
|
+$126M |
| 4 |
BridgeBio Pharma
BBIO
|
+$116M |
| 5 |
Dover
DOV
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Revolution Medicines
RVMD
|
+$713M |
| 2 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$355M |
| 3 |
CTRA
Coterra Energy
CTRA
|
+$289M |
| 4 |
Royalty Pharma
RPRX
|
+$259M |
| 5 |
Eli Lilly
LLY
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.29% |
| 2 | Healthcare | 14.03% |
| 3 | Financials | 12.39% |
| 4 | Industrials | 8.94% |
| 5 | Communication Services | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Moderna
MRNA
$54.1B
| $11M | 0.02% |
+156,716
| New | +$8.11M |
|
702
Monte Rosa Therapeutics
GLUE
$1.22B
| $10.9M | 0.02% |
450,000
+200,000
| +80% | +$3.78M |
|
703
Sun Communities
SUI
$14.1B
| $10.8M | 0.02% |
+90,000
| New | +$11.3M |
|
704
Newmark Group
NMRK
$2.65B
| $10.8M | 0.02% |
712,803
-152,197
| -18% | -$2.32M |
|
705
HP
HPQ
$29.2B
| $10.8M | 0.02% |
490,136
+71,100
| +17% | +$1.57M |
|
706
Vishay Intertechnology
VSH
$4.86B
| $10.7M | 0.02% |
199,616
-500,384
| -71% | -$20.5M |
|
707
Martin Marietta Materials
MLM
$35.7B
| $10.7M | 0.02% |
+18,539
| New | +$11M |
|
708
J.M. Smucker
SJM
$13.2B
| $10.7M | 0.02% |
95,027
-200
| -0.2% | -$20.4K |
|
709
Western Alliance Bancorporation
WAL
$8.69B
| $10.7M | 0.02% |
130,000
-20,000
| -13% | -$1.58M |
|
710
Encompass Health
EHC
$12B
| $10.7M | 0.02% |
105,490
-159,314
| -60% | -$16.5M |
|
711
lululemon athletica
LULU
$11B
| $10.7M | 0.01% |
93,300
-1,900
| -2% | -$254K |
|
|
OHAC
712
Oceanhawk Acquisition Corp
OHAC
$250M
| $10.6M | 0.01% |
+1,075,000
| New | +$10.6M |
|
713
Patria Investments
PAX
$1.75B
| $10.6M | 0.01% |
967,400
-32,600
| -3% | -$389K |
|
714
Invesco
IVZ
$14.2B
| $10.4M | 0.01% |
394,969
+38,800
| +11% | +$1.03M |
|
715
CoStar Group
CSGP
$12B
| $10.3M | 0.01% |
363,900
-14,200
| -4% | -$488K |
|
716
Clorox
CLX
$10.8B
| $10.3M | 0.01% |
107,753
+72,900
| +209% | +$7M |
|
|
SPCX
717
SpaceX
SPCX
$1.94T
| $10.3M | 0.01% |
+60,000
| New | +$10.2M |
|
|
WLII
718
Willow Lane Acquisition Corp II
WLII
| $10.2M | 0.01% |
+1,000,000
| New | +$10.1M |
|
|
MBVI
719
M3-Brigade Acquisition VI Corp
MBVI
$441M
| $10.1M | 0.01% |
1,000,000
| – | – |
|
|
PTRN
720
Pattern Group Inc
PTRN
$3.49B
| $10.1M | 0.01% |
+400,000
| New | +$6.79M |
|
|
BDCI
721
BTC Development Corp
BDCI
$353M
| $10.1M | 0.01% |
1,000,000
| – | – |
|
|
AEVA
722
Aeva Technologies
AEVA
$1.09B
| $10.1M | 0.01% |
350,000
-150,000
| -30% | -$2.95M |
|
723
GoDaddy
GDDY
$11.9B
| $10M | 0.01% |
118,000
-2,600
| -2% | -$219K |
|
|
TWO
724
DELISTED
Two Harbors Investment
TWO
| $9.98M | 0.01% |
803,897
+103,897
| +15% | +$1.24M |
|
725
Teck Resources
TECK
$34.5B
| $9.92M | 0.01% |
166,916
-450,000
| -73% | -$27.4M |
|
Similar funds
Adage Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.
- Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
- Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
- Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
- Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
- Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
- Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
- Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.
Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.